Company page

Quince Therapeutics, Inc.

Quince Therapeutics, Inc. is a public company trading under the ticker QNCX in the American market. The company has a market capitalization of approximately $17.93 million. Quince Therapeutics focuses on developing innovative therapies, though specific product details and financial metrics are not provided.